Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    IDEAYA Biosciences Inc.

    NASDAQ: IDYA · Real-Time Price · USD
    22.40
    0.22 (0.99%)
    At close: Jun 16, 2025, 3:59 PM

    IDEAYA Biosciences Statistics

    Share Statistics

    IDEAYA Biosciences has 87.58M shares outstanding. The number of shares has increased by 15.66% in one year.

    Shares Outstanding

    n/a
    		 87.58M

    Shares Change (YoY)

    n/a
    		 15.66%

    Shares Change (QoQ)

    n/a
    		 1.28%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 78.78M

    Failed to Deliver (FTD) Shares

    n/a
    		 678

    FTD / Avg. Volume

    n/a
    		 0.05%

    Short Selling Information

    The latest short interest is 10.5M, so 11.98% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.5M

    Short % of Shares Out

    n/a
    		 11.98%

    Short % of Float

    n/a
    		 14.14%

    Short Ratio (days to cover)

    n/a
    		 6.7

    Valuation Ratios

    The PE ratio is -7.65 and the forward PE ratio is -7.42. IDEAYA Biosciences's PEG ratio is -0.11.

    PE Ratio

    n/a
    		 -7.65

    Forward PE

    n/a
    		 -7.42

    PS Ratio

    n/a
    		 299.88

    Forward PS

    n/a
    		 3.1

    PB Ratio

    n/a
    		 1.98

    P/FCF Ratio

    n/a
    		 -8.35

    PEG Ratio

    n/a
    		 -0.11
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for IDEAYA Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 14.97, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 14.97

    Quick Ratio

    n/a
    		 14.97

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $53,435.11

    Profits Per Employee

    n/a
    		 $-2,095,244.27

    Employee Count

    n/a
    		 131

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -40.36% in the last 52 weeks. The beta is 0.02, so IDEAYA Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.02

    52-Week Price Change

    n/a
    		 -40.36%

    50-Day Moving Average

    n/a
    		 18.95

    200-Day Moving Average

    n/a
    		 24.51

    Relative Strength Index (RSI)

    n/a
    		 65.31

    Average Volume (20 Days)

    n/a
    		 1,424,752

    Income Statement

    In the last 12 months, IDEAYA Biosciences had revenue of 7M and earned -274.48M in profits. Earnings per share was -3.36.

    Revenue

    n/a
    		 7M

    Gross Profit

    n/a
    		 3.17M

    Operating Income

    n/a
    		 -326.98M

    Net Income

    n/a
    		 -274.48M

    EBITDA

    n/a
    		 -326.98M

    EBIT

    n/a
    		 -326.98M

    Earnings Per Share (EPS)

    n/a
    		 -3.36
    Full Income Statement

    Balance Sheet

    The company has 84.38M in cash and 19.17M in debt, giving a net cash position of 65.21M.

    Cash & Cash Equivalents

    n/a
    		 84.38M

    Total Debt

    n/a
    		 19.17M

    Net Cash

    n/a
    		 65.21M

    Retained Earnings

    n/a
    		 -622.84M

    Total Assets

    n/a
    		 1.1B

    Working Capital

    n/a
    		 657.03M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -247.58M and capital expenditures -3.86M, giving a free cash flow of -251.44M.

    Operating Cash Flow

    n/a
    		 -247.58M

    Capital Expenditures

    n/a
    		 -3.86M

    Free Cash Flow

    n/a
    		 -251.44M

    FCF Per Share

    n/a
    		 -3.08
    Full Cash Flow Statement

    Margins

    Gross margin is 45.23%, with operating and profit margins of -4671.07% and -3921.1%.

    Gross Margin

    n/a
    		 45.23%

    Operating Margin

    n/a
    		 -4671.07%

    Pretax Margin

    n/a
    		 -3921.1%

    Profit Margin

    n/a
    		 -3921.1%

    EBITDA Margin

    n/a
    		 -4671.07%

    EBIT Margin

    n/a
    		 -4671.07%

    FCF Margin

    n/a
    		 -3592.01%

    Dividends & Yields

    IDYA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IDYA is $55.5, which is 147.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $55.5

    Price Target Difference

    n/a
    		 147.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 12
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 12.19

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist